Case guide

UPDATED FEB 2026

MAT Patients and Dental Stigma

Part of the Suboxone Tooth Decay investigation

The short answer

People in recovery from opioid use disorder who experienced Suboxone-related tooth loss face a unique double stigma: societal bias against addiction, and the unfair association between visible tooth loss and substance use. These psychological and social harms are legally compensable non-economic damages, and addressing them with compassion and dignity is central to how these cases should be litigated.

People's Justice Research TeamUpdated February 20, 2026Fact-checked

Verified against court and regulatory records · No upfront fees · Your information is never sold

Free Case Review

Check your eligibility — free

Answer 2-3 quick questions to review your potential case.

Free · Confidential · About 2 minutes · A case specialist responds within 1 business day

Your answers are never sold or shared without your consent.

Understanding the Unique Harm to Patients in Recovery

Opioid use disorder is a chronic brain disorder, not a character defect. People who use Suboxone as part of their recovery are doing exactly what evidence-based medicine recommends — they are managing a medical condition under a physician's supervision. The profound injustice of Suboxone dental injury litigation is that these patients, many of whom worked incredibly hard to stabilize their health and rebuild their lives, were physically harmed by the very medication they took in good faith to get better. They did nothing wrong.

Yet the dental harm they sustained can compound stigma they already face. In some communities, visible tooth decay or tooth loss is unfairly associated with active drug use — a stereotype that ignores the many causes of dental disease and that is, in this case, a product of inadequately labeled pharmaceutical treatment rather than anything the patient did. People with Suboxone-related tooth loss have reported job discrimination, social withdrawal, difficulty in professional settings where appearance matters, and profound effects on self-esteem and relationships. These experiences are real, documented, and legally compensable.

How These Harms Are Documented and Compensated

In Suboxone dental injury litigation, non-economic damages for the psychological and social impacts of tooth loss are documented through mental health treatment records, sworn testimony describing the functional and emotional impact of tooth loss, statements from family members or co-workers, employment records showing changes after tooth loss, and expert testimony from psychologists or psychiatrists who can articulate the medical basis for emotional distress claims. Attorneys representing MAT patients approach this evidence with a framework that centers the patient's full humanity — their recovery journey, their responsibilities, and the additional burden placed on them by Indivior's failure to warn.

Key data

Data & Statistics

1 SOURCED FIGURE

No fault

FDA safety communication and medical literature

FAQ

Frequently Asked Questions

12 QUESTIONS

Suboxone is a brand-name prescription medication containing buprenorphine and naloxone. It is FDA-approved for the treatment of opioid use disorder as part of a medication-assisted treatment (MAT) program. Suboxone works by partially activating opioid receptors (via buprenorphine) while blocking the euphoric effects of other opioids (via naloxone), reducing cravings and withdrawal symptoms without producing significant intoxication. It is typically prescribed by addiction medicine specialists, primary care physicians, and psychiatrists who hold a DEA waiver for buprenorphine prescribing. Millions of people in the United States use Suboxone or similar buprenorphine products as part of their recovery, and the medication is considered a lifesaving component of evidence-based addiction treatment.

Dive deeper

Related Guides

11 GUIDES

The full investigation

Part of the Suboxone Tooth Decay Investigation